How bacteria develop resistance to programmable antibiotics
Antimicrobial resistance is one of the greatest challenges facing modern medicine. A new class of programmable antibiotics known as asobiotics can be used to treat bacterial infections when classical antibiotics fail. A team of researchers from TWINCORE, Center for Experimental and Clinical Infection Research; the RESIST Cluster of Excellence; and the Helmholtz Institute for RNA-based Infection…
We haven't written up this one. Phys.org has the full story — the link below goes straight to it.
